Skip to main content
Figure 5 | Journal of Experimental & Clinical Cancer Research

Figure 5

From: Arsenic trioxide exerts synergistic effects with cisplatin on non-small cell lung cancer cells via apoptosis induction

Figure 5

G0/G1 fraction analysis. FCM cell cycle analysis showed that the treatment of As2O3 and/or DDP did not significantly affect G0/G1 fractions of A549 and H460 cells compared with those of the control. The G0/G1 fraction ranged from 57% to 62% for control A549 cells and for A549 cells treated with As2O3 and/or DDP, and from 37% to 42% for control H460 cells and for H460 cells treated with As2O3 and/or DDP.

Back to article page